A carregar...
Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation
AIMS: Improved cancer survivorship has led to a higher number of anthracycline‐induced cardiomyopathy patients with end‐stage heart failure. We hypothesize that outcomes following continuous‐flow LVAD (CF‐LVAD) implantation in those with anthracycline‐induced cardiomyopathy are comparable with other...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318466/ https://ncbi.nlm.nih.gov/pubmed/33982867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13362 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|